Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

COVID-origins report sparks debate over major genome hub GISAID

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Nature 616, 13-14 (2023)


Updates & Corrections

  • Update 31 March 2023: GISAID has now removed the additional restrictions that it had introduced for access to the China CDC data; the story has been changed to reflect that.

  • Correction 31 March 2023: An earlier version of this story said that GISAID had clarified its rules for access to the China CDC data after the Zenodo report was posted; in fact it added more restrictions.


  1. Crits-Christoph, A. et al. Report at Zenodo (2023).

  2. Gao, G. et al. Preprint at Research Square (2022).

Download references


Latest on:

Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links